Your English writing platform
Discover LudwigSuggestions(2)
Exact(18)
Severe vision loss or serious PDR complications were uncommon with PRP or ranibizumab; however, the ranibizumab group had lower rates of developing vision-impairing diabetic macular edema and less visual field loss.
Sedation profile of the 51 patients with SAS scores documented pre and post is shown in Table 2. Adverse events during PR were uncommon with unintentional device removal in 7 (8%) patients.
The primary endpoint occurred in 3/4297 (0.07%) subjects in the bupropion group and in 4/2927 (0.14%) subjects in the placebo group (log-rank P value: 0.613).CV events in bupropion clinical trials for smoking cessation were uncommon, with no observed increase among subjects assigned to bupropion vs placebo.
RESULTS: Significant acute gastrointestinal (43% grade 2; 4% grade 3), hand and foot syndrome (21% grade 2), and transient hematologic (8% grade 3 or greater) events were uncommon with protocol mandated dose reductions of capecitabine grade 2 toxicity (43% of patients).
Solicited systemic reactions were uncommon, with mild to moderate headache being the most frequently observed event.
Surgical complications were uncommon with a conversion rate of 0.6% and no mortality.
Similar(42)
Periprosthetic fractures after total ankle arthroplasty are uncommon, with most cases occurring intraoperatively.
Fortunately, side effects are uncommon, with diarrhea, rash, or headache in fewer than 3% of people taking the medications.
Objectives and design iliac artery lesion after blunt trauma is uncommon, with only 12 previously reported cases.
A guilty plea in a corporate criminal investigation is uncommon, with most cases concluded by a deferred or nonprosecution agreement.
Pure MM is uncommon with respect to menstrually related migraine.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com